Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 11
Original Research
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,334 | Dovepress* | 6,487+ | 1,649 | 8,136 | |
| PubMed Central* | 847 | 221 | 1,068 | ||
| Totals | 7,334 | 1,870 | 9,204 | ||
| *Since 27 December 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar